» Articles » PMID: 35402494

Impact of Perioperative Multiple Doses of Glucocorticoids on Peripheral Blood Lymphocyte Subsets and Inflammatory Cytokines in Patients With Non-small Cell Lung Cancer

Overview
Journal Front Surg
Specialty General Surgery
Date 2022 Apr 11
PMID 35402494
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Surgery-induced immunosuppression is associated with infectious complications and cancer recurrence. This study aimed to characterize the effects of perioperative multiple doses of glucocorticoids on the peripheral immune environment in patients with non-small cell lung cancer.

Methods: In this retrospective study, surgical patients with lung cancer were included. Lymphocyte subsets, lymphocyte phenotypes, lymphocyte functions, and inflammatory cytokines were evaluated in the peripheral blood preoperatively, then at 1 day and 7 days postoperatively. Levels of immune cells and inflammatory factors were compared between those who did or did not receive glucocorticoids at all time points.

Results: Multiple doses or high doses (15-20 mg dexamethasone equivalents) of glucocorticoids that were all given within 24 h were associated with decreased absolute numbers of T cells, CD4and CD8T cells, B cells, and impaired T cells function at 1 day postoperatively while a single intraoperative low dose (5 mg) of dexamethasone had little influence on the peripheral environment. IL-1β, IL-6, and TNF-α were also more affected by multiple doses of glucocorticoids.

Conclusions: Among patients with lung cancer, perioperative multiple doses of glucocorticoids that are all given within a short time are associated with decreased immune cell counts and impaired T cells functions.

Citing Articles

Development and validation of a clinic machine-learning nomogram for the prediction of risk stratifications of prostate cancer based on functional subsets of peripheral lymphocyte.

Yang C, Liu Z, Fang Y, Cao X, Xu G, Wang Z J Transl Med. 2023; 21(1):465.

PMID: 37438820 PMC: 10339548. DOI: 10.1186/s12967-023-04318-w.

References
1.
Neeman E, Ben-Eliyahu S . Surgery and stress promote cancer metastasis: new outlooks on perioperative mediating mechanisms and immune involvement. Brain Behav Immun. 2012; 30 Suppl:S32-40. PMC: 3423506. DOI: 10.1016/j.bbi.2012.03.006. View

2.
Toner A, Ganeshanathan V, Chan M, Ho K, Corcoran T . Safety of Perioperative Glucocorticoids in Elective Noncardiac Surgery: A Systematic Review and Meta-analysis. Anesthesiology. 2016; 126(2):234-248. DOI: 10.1097/ALN.0000000000001466. View

3.
De Oliveira Jr G, McCarthy R, Turan A, Schink J, Fitzgerald P, Sessler D . Is dexamethasone associated with recurrence of ovarian cancer?. Anesth Analg. 2013; 118(6):1213-8. DOI: 10.1213/ANE.0b013e3182a5d656. View

4.
Craig S, Leaver H, Yap P, Pugh G, Walker W . Acute phase responses following minimal access and conventional thoracic surgery. Eur J Cardiothorac Surg. 2001; 20(3):455-63. DOI: 10.1016/s1010-7940(01)00841-7. View

5.
Tomazini B, Maia I, Cavalcanti A, Berwanger O, Rosa R, Veiga V . Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19: The CoDEX Randomized Clinical Trial. JAMA. 2020; 324(13):1307-1316. PMC: 7489411. DOI: 10.1001/jama.2020.17021. View